Literature DB >> 32296767

Structure and Dynamics of Adrenomedullin Receptors AM1 and AM2 Reveal Key Mechanisms in the Control of Receptor Phenotype by Receptor Activity-Modifying Proteins.

Yi-Lynn Liang1, Matthew J Belousoff1, Madeleine M Fletcher1, Xin Zhang1, Maryam Khoshouei2, Giuseppe Deganutti3, Cassandra Koole1, Sebastian G B Furness1, Laurence J Miller1,4, Debbie L Hay5, Arthur Christopoulos1, Christopher A Reynolds3, Radostin Danev6, Denise Wootten1,7, Patrick M Sexton1,7.   

Abstract

Adrenomedullin (AM) and calcitonin gene-related peptide (CGRP) receptors are critically important for metabolism, vascular tone, and inflammatory response. AM receptors are also required for normal lymphatic and blood vascular development and angiogenesis. They play a pivotal role in embryo implantation and fertility and can provide protection against hypoxic and oxidative stress. CGRP and AM receptors are heterodimers of the calcitonin receptor-like receptor (CLR) and receptor activity-modifying protein 1 (RAMP1) (CGRPR), as well as RAMP2 or RAMP3 (AM1R and AM2R, respectively). However, the mechanistic basis for RAMP modulation of CLR phenotype is unclear. In this study, we report the cryo-EM structure of the AM1R in complex with AM and Gs at a global resolution of 3.0 Å, and structures of the AM2R in complex with either AM or intermedin/adrenomedullin 2 (AM2) and Gs at 2.4 and 2.3 Å, respectively. The structures reveal distinctions in the primary orientation of the extracellular domains (ECDs) relative to the receptor core and distinct positioning of extracellular loop 3 (ECL3) that are receptor-dependent. Analysis of dynamic data present in the cryo-EM micrographs revealed additional distinctions in the extent of mobility of the ECDs. Chimeric exchange of the linker region of the RAMPs connecting the TM helix and the ECD supports a role for this segment in controlling receptor phenotype. Moreover, a subset of the motions of the ECD appeared coordinated with motions of the G protein relative to the receptor core, suggesting that receptor ECD dynamics could influence G protein interactions. This work provides fundamental advances in our understanding of GPCR function and how this can be allosterically modulated by accessory proteins.
Copyright © 2020 American Chemical Society.

Entities:  

Year:  2020        PMID: 32296767      PMCID: PMC7155201          DOI: 10.1021/acsptsci.9b00080

Source DB:  PubMed          Journal:  ACS Pharmacol Transl Sci        ISSN: 2575-9108


  82 in total

1.  Fetal-derived adrenomedullin mediates the innate immune milieu of the placenta.

Authors:  Manyu Li; Nicole M J Schwerbrock; Patricia M Lenhart; Kimberly L Fritz-Six; Mahita Kadmiel; Kathleen S Christine; Daniel M Kraus; Scott T Espenschied; Helen H Willcockson; Christopher P Mack; Kathleen M Caron
Journal:  J Clin Invest       Date:  2013-05-01       Impact factor: 14.808

Review 2.  Receptor Activity-Modifying Proteins (RAMPs): New Insights and Roles.

Authors:  Debbie L Hay; Augen A Pioszak
Journal:  Annu Rev Pharmacol Toxicol       Date:  2015-10-23       Impact factor: 13.820

Review 3.  Role of CGRP-receptor component protein (RCP) in CLR/RAMP function.

Authors:  Ian M Dickerson
Journal:  Curr Protein Pept Sci       Date:  2013-08       Impact factor: 3.272

Review 4.  Adrenomedullin as a potential therapeutic agent for inflammatory bowel disease.

Authors:  Shinya Ashizuka; Haruhiko Inatsu; Kyoko Inagaki-Ohara; Toshihiro Kita; Kazuo Kitamura
Journal:  Curr Protein Pept Sci       Date:  2013-06       Impact factor: 3.272

5.  Cryo-electron microscopy modeling by the molecular dynamics flexible fitting method.

Authors:  Kwok-Yan Chan; Leonardo G Trabuco; Eduard Schreiner; Klaus Schulten
Journal:  Biopolymers       Date:  2012-09       Impact factor: 2.505

6.  Receptor activity-modifying protein dependent and independent activation mechanisms in the coupling of calcitonin gene-related peptide and adrenomedullin receptors to Gs.

Authors:  Michael J Woolley; Christopher A Reynolds; John Simms; Christopher S Walker; Juan Carlos Mobarec; Michael L Garelja; Alex C Conner; David R Poyner; Debbie L Hay
Journal:  Biochem Pharmacol       Date:  2017-07-11       Impact factor: 5.858

7.  Calcitonin Gene-Related Peptide Induces HIV-1 Proteasomal Degradation in Mucosal Langerhans Cells.

Authors:  Morgane Bomsel; Yonatan Ganor
Journal:  J Virol       Date:  2017-11-14       Impact factor: 5.103

8.  Structural Basis for Receptor Activity-Modifying Protein-Dependent Selective Peptide Recognition by a G Protein-Coupled Receptor.

Authors:  Jason M Booe; Christopher S Walker; James Barwell; Gabriel Kuteyi; John Simms; Muhammad A Jamaluddin; Margaret L Warner; Roslyn M Bill; Paul W Harris; Margaret A Brimble; David R Poyner; Debbie L Hay; Augen A Pioszak
Journal:  Mol Cell       Date:  2015-05-14       Impact factor: 17.970

9.  Accelerated cryo-EM structure determination with parallelisation using GPUs in RELION-2.

Authors:  Dari Kimanius; Björn O Forsberg; Sjors Hw Scheres; Erik Lindahl
Journal:  Elife       Date:  2016-11-15       Impact factor: 8.140

10.  Cryo-EM structure of the active, Gs-protein complexed, human CGRP receptor.

Authors:  Yi-Lynn Liang; Maryam Khoshouei; Giuseppe Deganutti; Alisa Glukhova; Cassandra Koole; Thomas S Peat; Mazdak Radjainia; Jürgen M Plitzko; Wolfgang Baumeister; Laurence J Miller; Deborah L Hay; Arthur Christopoulos; Christopher A Reynolds; Denise Wootten; Patrick M Sexton
Journal:  Nature       Date:  2018-09-12       Impact factor: 49.962

View more
  21 in total

1.  Molecular interaction of an antagonistic amylin analog with the extracellular domain of receptor activity-modifying protein 2 assessed by fluorescence polarization.

Authors:  Sangmin Lee; Augen A Pioszak
Journal:  Biophys Chem       Date:  2020-09-20       Impact factor: 2.352

Review 2.  Membranes under the Magnetic Lens: A Dive into the Diverse World of Membrane Protein Structures Using Cryo-EM.

Authors:  Sarah J Piper; Rachel M Johnson; Denise Wootten; Patrick M Sexton
Journal:  Chem Rev       Date:  2022-07-18       Impact factor: 72.087

Review 3.  Regulation and Dysregulation of Endothelial Permeability during Systemic Inflammation.

Authors:  Katharina E M Hellenthal; Laura Brabenec; Nana-Maria Wagner
Journal:  Cells       Date:  2022-06-15       Impact factor: 7.666

4.  Picomolar Affinity Antagonist and Sustained Signaling Agonist Peptide Ligands for the Adrenomedullin and Calcitonin Gene-Related Peptide Receptors.

Authors:  Jason M Booe; Margaret L Warner; Augen A Pioszak
Journal:  ACS Pharmacol Transl Sci       Date:  2020-07-24

5.  GPCRsignal: webserver for analysis of the interface between G-protein-coupled receptors and their effector proteins by dynamics and mutations.

Authors:  Przemysław Miszta; Paweł Pasznik; Szymon Niewieczerzał; Jakub Jakowiecki; Sławomir Filipek
Journal:  Nucleic Acids Res       Date:  2021-07-02       Impact factor: 16.971

6.  Biochemical characterization of G protein coupling to calcitonin gene-related peptide and adrenomedullin receptors using a native PAGE assay.

Authors:  Amanda M Roehrkasse; Margaret L Warner; Jason M Booe; Augen A Pioszak
Journal:  J Biol Chem       Date:  2020-06-02       Impact factor: 5.157

7.  Cryo-electron microscopy structure of the glucagon receptor with a dual-agonist peptide.

Authors:  Rulue Chang; Xin Zhang; Anna Qiao; Antao Dai; Matthew J Belousoff; Qiuxiang Tan; Lijun Shao; Li Zhong; Guangyao Lin; Yi-Lynn Liang; Limin Ma; Shuo Han; Dehua Yang; Radostin Danev; Ming-Wei Wang; Denise Wootten; Beili Wu; Patrick M Sexton
Journal:  J Biol Chem       Date:  2020-05-05       Impact factor: 5.157

8.  Current Trends in GPCR Allostery.

Authors:  Khuraijam Dhanachandra Singh; Sadashiva S Karnik
Journal:  J Membr Biol       Date:  2021-01-20       Impact factor: 1.843

9.  Pharmacological characterisation of mouse calcitonin and calcitonin receptor-like receptors reveals differences compared with human receptors.

Authors:  Michael L Garelja; Rebekah L Bower; Margaret A Brimble; Shanan Chand; Paul W R Harris; Muhammad Aqfan Jamaluddin; Jakeb Petersen; Andrew Siow; Christopher S Walker; Debbie L Hay
Journal:  Br J Pharmacol       Date:  2021-10-15       Impact factor: 8.739

10.  Discovery of a First-in-Class Potent Small Molecule Antagonist against the Adrenomedullin-2 Receptor.

Authors:  Paris Avgoustou; Ameera B A Jailani; Jean-Olivier Zirimwabagabo; Matthew J Tozer; Karl R Gibson; Paul A Glossop; James E J Mills; Roderick A Porter; Paul Blaney; Peter J Bungay; Ning Wang; Alice P Shaw; Kamilla J A Bigos; Joseph L Holmes; Jessica I Warrington; Timothy M Skerry; Joseph P A Harrity; Gareth O Richards
Journal:  ACS Pharmacol Transl Sci       Date:  2020-06-25
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.